Jean-Frederic Viret - Chief Financial Officer, Coherus Biosciences, Inc

As of February 3, 2021


Jean-Frederic Viret Net Worth

  • Net worth is estimated to be at least $3.57M
  • Owns at least 61,295 units of Coherus Biosciences, Inc stock
  • Sold an estimated value of $3.12M in the last 7 years at Coherus Biosciences, Inc

Jean-Frederic Viret Compensation at Coherus Biosciences, Inc in 2020

  • Received a total compensation of $2,070,512

Jean-Frederic Viret Trading

  • Largest purchase of shares was 40,000 units , worth over $402K on January 27, 2021
  • Largest sale of shares was 46,144 units , worth over $920.74K on January 27, 2021
  • In total has made about 36 transactions over 7 years
  • Usually trades in January, with the busiest year in 2019
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Jean-Frederic Viret Mailing Address

  • Mailing address is Anesiva, Inc. 650 Gateway Blvd. South San Francisco CA 94080 CA

Coherus Biosciences, Inc Executive Compensation

Name
Year
Total
Dennis M. Lanfear 2020 $7,278,761
Dennis M. Lanfear 2019 $5,361,707
Dennis M. Lanfear 2018 $3,919,780
Jean-Frédéric Viret, Ph.D. 2020 $2,070,512
Jean-Frédéric Viret, Ph.D. 2019 $1,829,591
Jean-Frédéric Viret, Ph.D. 2018 $1,478,211
Vincent Anicetti 2020 $2,031,220
Vincent Anicetti 2019 $1,810,841
Vincent Anicetti 2018 $1,818,680
Vladimir Vexler, Ph.D. 2020 $2,004,299
Vladimir Vexler, Ph.D. 2019 $1,757,229
Vladimir Vexler, Ph.D. 2018 $1,355,163
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1512762/000155837021004117/tmb-20210521xdef14a.htm

Coherus Biosciences, Inc Insider Trading

  • The most recent transaction was 3,507 units sold on October 19, 2021 by McDavid Stilwell worth over $58.92K
  • In the last 7 years, insiders at Coherus Biosciences, Inc sold an estimated value of $103.39M and bought an estimated value of $14.46M
  • The most active traders are Jean-Frederic Viret, Chief Financial Officer,  Alan C Herman, Chief Scientific Officer,  and Vincent R Anicetti, Chief Operating Officer
  • Insider trading is most common in January, with the busiest year in 2016

Coherus BioSciences, Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1